The impact of letermovir prophylaxis in matched sibling donor haematopoietic stem cell transplantation: Selecting the appropriate population for optimal prophylactic therapy

Documenti analoghi

• Clinical and genetic profiles and outcomes of allogeneic haematopoietic stem cell transplantation in secondary myelodysplastic syndrome following aplastic anaemia
  di: Jia Li, et al.
  Pubblicazione: (2024)
• The Efficacy and Safety of the Addition of Mitoxantrone Hydrochloride Liposome in Conditioning Regimen for High‐Risk Acute Myeloid Leukemia
  di: Xiaoyu Zhang, et al.
  Pubblicazione: (2025)
• CSF3R Mutations in Hematological Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
  di: Jiaxin Cao, et al.
  Pubblicazione: (2025)
• Optimizing treatment selection and timing of allogeneic haematopoietic stem cell transplantation in acute myeloid leukaemia with concurrent feline McDonough sarcoma (FMS)‐like tyrosine kinase 3 internal tandem duplication, nucleophosmin 1 and deoxyribonucleic acid (DNA) methyltransferase 3 alpha mutations
  di: Ruixin Li, et al.
  Pubblicazione: (2026)
• Real‐life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients
  di: Grégoire Saltiel, et al.
  Pubblicazione: (2024)